Complete endosonographic intrathoracic nodal staging of lung cancer patients in whom SABR is considered.

Complete endosonographic intrathoracic nodal staging of lung cancer patients in whom SABR is considered. - STAGE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44668

Enrollment

102

Registered

2013-10-28

Start date

2013-11-13

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (suspected) non small cell lung cancer absence of distant metastases SABR is contemplated

Exclusion criteria

Exclusion criteria: bulky nodal disease based on PET-CT contra-indication for endosonography

Design outcomes

Primary

Measure	Time frame
Change of loco-regional nodal status (N0-N3) after complete endosonographic staging (EBUS+EUS-B) of the hilus and mediastinum versus initial PET-CT based loco-regional nodal status. The primary hypothesis will be tested in patients with (suspected) non-small cell lung cancer (NSCLC) when SABR with curative intent is considered.	—

Secondary

Measure	Time frame
Radiotherapy plan comparisons for the pre EUS-EBUS staging versus post-staging target volumes	—

Countries

Netherlands

Outcome results